LKC Technologies
English
English Español Português 日本
  • Products
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Sensor Strips
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Applications
    • Visual Electrophysiology
      • Electroretinography (ERG)
      • Visual Evoked Potential (VEP)
    • Clinical Conditions
      • Diabetic Retinopathy
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Animal Applications
  • Resources
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Research
    • Podcasts
    • Blog
    • Videos
    • Software
  • About LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • Testimonials
    • History
  • Contact
  • Academy
  • Buy Sensor Strips
  • Schedule a Demo

Research

Show:

RETeval

Sensor Strips

RETevet

Menu
  • Animal
  • Central Retinal Vein Occlusion
  • Diabetic Retinopathy
  • Flicker ERG
  • Inherited Retinal Diseases
  • Optic Nerve Disorders
  • Pediatric
  • Photopic Negative Response
  • Sensor Strips

Native components analysis of the spectral electroretinogram

October 1, 2025
Tyler CW, Liang M, Zhou Z, Likova LT. Native components analysis of the spectral electroretinogram. Vision Res. Published online October 2025.

An in-depth characterization of development-related electroretinographical and morphological changes in Landrace pigs

September 25, 2025
Skrzypczyk L, Ackermann BC, Augustin VA, et al. An in-depth characterization of development-related electroretinographical and morphological changes in Landrace pigs. Doc Ophthalmol. Published online September 25, 2025.

Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study

September 8, 2025
Yakimov V, Neuwinger L, Weber MM, et al. Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study. Eur Arch Psychiatry Clin Neurosci. Published online September 8, 2025.

Bilateral multiple retinal pigment epithelial detachments

September 5, 2025
Yoshida A, Shibuya M, Shimada Y, Igawa Y, Tachibana M, Shinoda K. Bilateral multiple retinal pigment epithelial detachments. Doc Ophthalmol. Published online September 5, 2025.

CERKL related autosomal recessive retinitis pigmentosa - A report on four affected members from a single family

September 1, 2025
Telukunta P, Parameswarappa DC, Padhy SK, Balasubramanian J, Jalali S. CERKL related autosomal recessive retinitis pigmentosa – A report on four affected members from a single family. Indian Journal of Ophthalmology – Case Reports. Published online September 2025.

Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes

September 1, 2025
Moore F, Phillips S, Rubenstein D, et al. Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes. Trans Vis Sci Tech. Published online September 2025.

Global motion coherent deficits in individuals with autism spectrum disorder and their family members are associated with retinal function

August 2, 2025
Lee IO, Fritsch DM, Kerz M, et al. Global motion coherent deficits in individuals with autism spectrum disorder and their family members are associated with retinal function. Sci Rep. Published online August 2, 2025.

Case of autosomal dominant optic atrophy with relatively good visual function

August 1, 2025
Tachibana M, Hayashi T, Igawa Y, et al. Case of autosomal dominant optic atrophy with relatively good visual function. BMC Ophthalmology. Published online August 2025.

Infrared Photography: A Novel Diagnostic Approach for Ocular Surface Abnormalities Due to Vitamin A Deficiency

July 30, 2025
Fukuoka H, Sotozono C. Infrared Photography: A Novel Diagnostic Approach for Ocular Surface Abnormalities Due to Vitamin A Deficiency. Diagnostics. Published online July 30, 2025.

Electroretinographic Findings in Fragile X, Premutation, and Controls: A Study of Biomarker Correlations

July 16, 2025
Hasan H, Biag HMB, Santos ER, et al. Electroretinographic Findings in Fragile X, Premutation, and Controls: A Study of Biomarker Correlations. International Journal of Molecular Sciences. Published online July, 16, 2025.

Electroretinogram as an Early Diagnostic Biomarker for Acute Retinal Necrosis: A Multicenter Comparative Study

July 13, 2025
Fukuyama S, Maruyama K, Yoshida M, et al. Electroretinogram as an Early Diagnostic Biomarker for Acute Retinal Necrosis: A Multicenter Comparative Study. Ocular Immunology and Inflammation. Published online July 13, 2025.

Light-adapted electroretinograms of eyes with cataract recorded using the HE-2000 system before and after mydriasis

July 9, 2025
Chiku Y, Hirano T, Ito S, Akahane K, Murata T. Light-adapted electroretinograms of eyes with cataract recorded using the HE-2000 system before and after mydriasis. Sci Rep. Published online July 9, 2025.

A Surgical Approach for Optic Nerve Crush in a Rabbit Model

July 8, 2025
Jang K, Ross AKM, Jovel P, Heng K, Goldberg JL, Chiang B. A Surgical Approach for Optic Nerve Crush in a Rabbit Model. Journal of Visualized Experiments (JoVE). Published online July 8, 2025.

High-dose intravitreal topotecan (100 mcg/0.1cc) as monotherapy for recurrent/refractory intraocular retinoblastoma in seven eyes

July 3, 2025
Vempuluru VS, Raval V, Kaliki S. High-dose intravitreal topotecan (100 mcg/0.1cc) as monotherapy for recurrent/refractory intraocular retinoblastoma in seven eyes. Retina. Published online July 3, 2025.

Early-Onset Retinal Dysfunction Associated with Novel WDR19 Variants in Sensenbrenner Syndrome

July 3, 2025
Wójcik-Niklewska B, Oliwa Z, Zdort Z, Smędowski A. Early-Onset Retinal Dysfunction Associated with Novel WDR19 Variants in Sensenbrenner Syndrome. Diagnostics. Published online July 3, 2025.

Report of the 2023 Mary Tyler Moore Vision Initiative Workshop

July 1, 2025
Levine SR, Markel DS, Myers MG, et al. Report of the 2023 Mary Tyler Moore Vision Initiative Workshop. Trans Vis Sci Tech. Published online July 2025.

Predicting Progression to Vision-Threatening Complications in Diabetic Retinopathy

June 17, 2025
Predicting Progression to Vision-Threatening Complications in Diabetic Retinopathy. Davis, C. Quentin et al. Ophthalmology Science, Volume 0, Issue 0, 100859. Published online June 17, 2025.

Establishing a Novel Neurofunctional Pre-Season Baseline for Sports-Related Concussion in Men and Women Collegiate Athletics

June 1, 2025
Vincent JC, Divine JG, At AKH. Establishing a Novel Neurofunctional Pre-Season Baseline for Sports-Related Concussion in Men and Women Collegiate Athletics. Published online June 2025.

Vitamin A deficiency presenting with ptosis and optic neuropathy in child with autism spectrum disorder

June 1, 2025
Morita R, Kato K, Nagashima R, Momose M, Mori S, Kondo M. Vitamin A deficiency presenting with ptosis and optic neuropathy in child with autism spectrum disorder. Doc Ophthalmol. Published online June 1, 2025.

Brief report: harmonic analysis of the 30 Hz flicker ERG in early-stage diabetic retinopathy

May 31, 2025
McAnany JJ, Park JC. Brief report: harmonic analysis of the 30 Hz flicker ERG in early-stage diabetic retinopathy. Doc Ophthalmol. Published online May 31, 2025.

Can a Portable Flash Visual Evoked Potential (VEP) Device Identify Chiasmal Decussation Anomalies in Albinism?

May 30, 2025
Keeling E, Carter P, Musa AM, Shawkat F, Lee H, Self JE. Can a Portable Flash Visual Evoked Potential (VEP) Device Identify Chiasmal Decussation Anomalies in Albinism? Diagnostics. Published online May 30, 2025.

Can a Portable Flash Visual Evoked Potential (VEP) Device Identify Chiasmal Decussation Anomalies in Albinism?

May 30, 2025
Keeling E, Carter P, Musa AM, Shawkat F, Lee H, Self JE. Can a Portable Flash Visual Evoked Potential (VEP) Device Identify Chiasmal Decussation Anomalies in Albinism? Diagnostics. Published online May 30, 2025.

The Relationship Between the Ganglion Cell–Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study

May 1, 2025
Sarnat-Kucharczyk M, Pojda-Wilczek D, Mrukwa-Kominek E, Kos-Kudła B, Janik MA, Janik P. The Relationship Between the Ganglion Cell–Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study. Cancers. Published online May 1, 2025.

Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes

May 1, 2025
Fickweiler W, Sampani K, Markel DS, Levine SR, Sun JK, Gardner TW. Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes. Trans Vis Sci Tech. Published online May 2025.

Cancer-Associated Retinopathy Presenting as Panuveitis Secondary to Minimally Invasive Follicular Thyroid Carcinoma

April 25, 2025
Arnold N, Mishra A, Seamone M. Cancer-Associated Retinopathy Presenting as Panuveitis Secondary to Minimally Invasive Follicular Thyroid Carcinoma. Journal of VitreoRetinal Diseases. Published online April 25, 2025.

Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

April 24, 2025
de Deus M, Petit C, Moulard M, et al. Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial. Front Psychiatry. Published online April 24, 2025.

Synthetic electroretinogram signal generation using a conditional generative adversarial network

April 16, 2025
Kulyabin M, Zhdanov A, Lee IO, et al. Synthetic electroretinogram signal generation using a conditional generative adversarial network. Doc Ophthalmol. Published online April 16, 2025.

Electroretinography Biomarkers Indicate Disrupted Visual Processing in Fragile X Syndrome: A Comparative Study with Healthy Controls (P2-6.015)

April 8, 2025
Pu Q, Sekhar T, Stanley M, Berry-Kravis E. Electroretinography Biomarkers Indicate Disrupted Visual Processing in Fragile X Syndrome: A Comparative Study with Healthy Controls (P2-6.015). Neurology. 2025;104(7_Supplement_1):1873. Published online April 8, 2025.

Could a hand-held, visual electrophysiology device theoretically reduce diagnostic waiting times for complex eye conditions in the NHS?

March 28, 2025
Bayer S, Garillo D, Penn M, et al. Could a hand-held, visual electrophysiology device theoretically reduce diagnostic waiting times for complex eye conditions in the NHS? A Discrete Event Simulation (DES) modelling study. Published online March, 28, 2025.

Vitamin A deficiency masquerading as cancer-associated retinopathy

March 27, 2025
Karthik N, Sharma S. Vitamin A deficiency masquerading as cancer-associated retinopathy. Canadian Journal of Ophthalmology. Published online March 27, 2025.
Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9
  • Products
    • RETeval
    • UTAS mf/PERG
    • Sensor Strips
    • RETevet
  • Electrophysiology Tests
    • Electroretinography (ERG)
    • Full-Field ERG (ffERG)
    • Pattern ERG (PERG)
    • Multifocal ERG (mfERG)
    • Visual Evoked Potential (VEP)
    • Address20501 Seneca Meadows Parkway, Suite 305
      Germantown, MD 20876 USA
    • Phone+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • International Distributors
      • Medical Device Distributors
      • Veterinary Device Distributors
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • Accessibility Statement
  • Terms & Conditions
  • Certifications
  • Privacy Policy
  • Careers

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity